Format

Send to

Choose Destination
Curr Protoc Pharmacol. 2013 Oct 8;62:Unit 1.9.. doi: 10.1002/0471141755.ph0109s62.

Characterization of P1 (adenosine) purinoceptors.

Author information

1
AbbVie, Global Research and Development, North Chicago, Illinois.

Abstract

The purine nucleoside adenosine (ADO) is an important modulator of cellular function in mammalian tissues, modulating cellular function and neuronal excitability via interactions with different cell surface receptor subtypes that are heterogeneously distributed in both the mammalian CNS and peripheral tissues. Four ADO receptor subtypes have been cloned and characterized. Described in this unit are three radioligand binding assays for pharmacological characterization of the high-affinity ADO receptor subtypes A1, A2A, and A3 receptors. Pharmacological characterization of the low-affinity A2B receptor has been enabled by the use of tritiated xanthine PSB-603. Because receptor localization is an important criterion for differentiation of receptor subtypes, a support protocol that describes the methodology for the localization of ADO receptors in rat brain tissue using autoradiography is also included.

KEYWORDS:

G protein-coupled receptor; adenosine; neuromodulation

PMID:
24510716
DOI:
10.1002/0471141755.ph0109s62
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center